Cargando…
In vivo demonstration of microvascular thrombosis in severe COVID-19
Several autopsy studies showed microthrombi in pulmonary circulation of severe COVID-19 patients. The major limitation of these investigations is that the autopsy provided static information. Some of these alterations could be secondary to the disseminated intravascular coagulation (DIC) observed as...
Autores principales: | do Espírito Santo, Douglas Alexandre, Lemos, Anna Cristina Bertoldi, Miranda, Carlos Henrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424241/ https://www.ncbi.nlm.nih.gov/pubmed/32789730 http://dx.doi.org/10.1007/s11239-020-02245-x |
Ejemplares similares
-
Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021) -
Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2020) -
Microvascular Thrombosis as a Critical Factor in Severe COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2023) -
In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography
por: Si-Mohamed, Salim, et al.
Publicado: (2020) -
Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review
por: Gianni, Panagiota, et al.
Publicado: (2022)